GLP-1 Receptor Agonists Among Patients With Overweight or Obesity, Diabetes, and HFpEF on SGLT2 Inhibitors
Related Posts
Abhyankar DA, Pennino MR, Pedersen LN, Grogan F, Klass A, Valenzuela Ripoll C, Ng S, Guo Z, Hajirezaei H, Rentschler SL, Robinson CG, Cuculich PS,[...]
Fonarow GC, Keykhaei M. Quadruple therapy in HFpEF with type 2 diabetes: Time to implement? Kardiol Pol. 2025 Dec 18. doi: 10.33963/v.phj.110268. Epub ahead of[...]
Lilley B, Amubieya O, Ziaeian B. The Effect of Urban Heat Island Intensity on the Rate of Emergency Department Visits for Acute Myocardial Infarctions. Eur[...]